Tempest Therapeutics (TPST) plans vote on supermajority and written-consent changes
Tempest Therapeutics will hold a virtual Special Meeting on July 27, 2026, to vote on amending its Restated Certificate of Incorporation. The proposed changes aim to permit stockholder action by written consent and replace certain existing supermajority voting requirements with a majority-of-outstanding standard, aligning …